Feasibility, Acceptability, and Preliminary Efficacy of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents in China: A Pilot Study

被引:0
|
作者
Pan, Mei-Bong [1 ]
Liu, Xue-Ying [1 ]
Gao, Xue [1 ]
Fu, Zhong-Fang [2 ,3 ]
Liu, Lu [1 ]
Li, Hai-Mei [1 ]
Wang, Yu-Feng [1 ]
Qian, Qiu-Jin [1 ]
机构
[1] Peking Univ, Peking Univ Sixth Hosp, NHC Key Lab Mental Hlth, Natl Clin Res Ctr Mental Disorders,Inst Mental Hlt, Beijing, Peoples R China
[2] Peking Univ, Sch Psychol & Cognit Sci, Beijing, Peoples R China
[3] Peking Univ, Beijing Key Lab Behav & Mental Hlth, Beijing, Peoples R China
关键词
Unified Protocol for Transdiagnostic Treatment of Emotional Disorders; adolescents; emotional disorders; feasibility study; DEPRESSIVE-DISORDERS; ANXIETY DISORDERS; CHILD; RESILIENCE; SYMPTOMS; VALIDITY; SCALE; PSYCHOPATHOLOGY; RELIABILITY; PREVALENCE;
D O I
10.1016/j.beth.2024.05.003
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Currently, there is a lack of cost-effective and accessible intervention resources for Chinese adolescents with emotional disorders. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A), which aims to apply transdiagnostic treatment principles to target core dysfunctions across a range of emotional disorders with a single protocol, could fill this gap. We first modified the UP-A for use in the Chinese cultural context and then assessed its feasibility, acceptability, and preliminary efficacy using a single-arm design. Twenty-four Chinese adolescents (14.1 +/- 1.2 years old) with emotional disorders completed a 12-week group UP-A intervention along with their parents. Multiple outcomes were evaluated at five time points: pretreatment (T1), week 4 (T2), week 8 (T3), posttreatment (T4), and 3-month follow-up (T5). The results showed a low dropout rate (16.7%), high attendance (at 10.2 +/- 1.6 sessions in adolescents and 10.7 +/- 2.0 sessions in parents), and sufficient participant satisfaction. Adolescents exhibited significant decreases in emotional disorder severity (g =-1.298 to-1.341) and emotional symptoms (g =-0.440 to-1.988) and significant improvements in emotion regulation (ER) strategies, resilience, functional outcomes, and executive function. The efficacy of the intervention was significant starting at T2 and was maintained at T4 and T5. Exploratory analyses revealed that predictors of treatment outcomes included the presence of multiple comorbidities, the severity of emotional disorders, adaptive ER strategies, and resilience at T1. This study demonstrated the feasibility, acceptability, and preliminary efficacy of the Chinese version of the UP-A, and future randomized controlled trials are warranted.
引用
收藏
页码:145 / 161
页数:17
相关论文
共 50 条
  • [41] APPLICATION OF THE UNIFIED PROTOCOL FOR THE TRANSDIAGNOSTIC TREATMENT OF EMOTIONAL DISORDERS TO FAMILY CAREGIVERS OF PATIENTS WITH DEMENTIA
    Leon-Casas, Irene
    Rodriguez-Mora, Alvaro
    ACCION PSICOLOGICA, 2022, 19 (02): : 45 - 62
  • [42] PSICE Project Protocol: Evaluation of the Unified Protocol for Transdiagnostic Treatment for Adolescents with Emotional Symptoms in School Settings
    Fonseca-Pedrero, Eduardo
    Perez-Albeniz, Alicia
    Al-Halabi, Susana
    Lucas-Molina, Beatriz
    Ortuno-Sierra, Javier
    Diez-Gomez, Adriana
    Perez-Saenz, Julia
    Inchausti, Felix
    Garcia, Ana Valero V.
    Garcia, Andrea Gutierrez
    Solana, Rebeca Aritio
    Rodenas-Perea, Gabriel
    Clemente, Maria P. De Vicente
    Lopez, Ana Ciarreta
    Debbane, Martin
    CLINICA Y SALUD, 2023, 34 (01): : 15 - 22
  • [43] Contextual Adaptation of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Victims of the Armed Conflict in Colombia: A Case Study
    Castro-Camacho, Leonidas
    David Moreno, Julian
    Naismith, Iona
    COGNITIVE AND BEHAVIORAL PRACTICE, 2019, 26 (02) : 366 - 380
  • [44] A pilot trial of a transdiagnostic treatment for emotional disorders-a locally adapted variant of group Unified Protocol (UP) for Chinese adults
    Powell, Candice L. Y. M.
    Farchione, Todd J.
    Barlow, David H.
    Leung, Patrick W. L.
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2021, 11 (05) : 1142 - 1150
  • [45] Effectiveness of the Unified Protocol for the transdiagnostic treatment of emotional disorders in online and group format in Argentina: study protocol for a randomized controlled trial
    Celleri, Milagros
    Cremades, Camila F.
    Etchevers, Martin J.
    Garay, Cristian J.
    TRIALS, 2023, 24 (01)
  • [46] Effectiveness of the Unified Protocol for the transdiagnostic treatment of emotional disorders in online and group format in Argentina: study protocol for a randomized controlled trial
    Milagros Celleri
    Camila F. Cremades
    Martin J. Etchevers
    Cristian J. Garay
    Trials, 24
  • [47] Predictors of treatment outcome for the unified protocol for transdiagnostic treatment of emotional disorders in children (UP-C)
    Kennedy, Sarah M.
    Tonarely, Niza A.
    Sherman, Jamie A.
    Ehrenreich-May, Jill
    JOURNAL OF ANXIETY DISORDERS, 2018, 57 : 66 - 75
  • [48] Premature termination of the unified protocol for the transdiagnostic treatment of emotional disorders: The role of ambivalence towards change
    Oliveira, Joao Tiago
    Sousa, Ines
    Ribeiro, Antonio P.
    Goncalves, Miguel M.
    CLINICAL PSYCHOLOGY & PSYCHOTHERAPY, 2022, 29 (03) : 1089 - 1100
  • [49] A Contextual Adaptation of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Victims of the Armed Conflict in Colombia
    Castro-Camacho, Leonidas
    Rattner, Michel
    Quant, Diana Melisa
    Gonzalez, Laura
    Moreno, Julian David
    Ametaj, Amantia
    COGNITIVE AND BEHAVIORAL PRACTICE, 2019, 26 (02) : 351 - 365
  • [50] Blended transdiagnostic group CBT for emotional disorders: A feasibility trial protocol
    Diaz-Garcia, Amanda
    Gonzalez-Robles, Alberto
    Garcia-Palacios, Azucena
    Fernandez-Felipe, Isabel
    Tur, Cintia
    Castilla, Diana
    Botella, Cristina
    INTERNET INTERVENTIONS-THE APPLICATION OF INFORMATION TECHNOLOGY IN MENTAL AND BEHAVIOURAL HEALTH, 2021, 23